Work

Will Kinase Inhibitors Make it as Glioblastoma Drugs?

Year: 2011

Type: book-chapter

Source: Current topics in microbiology and immunology

DOI: 10.1007/82_2011_178

Authors: Ingo K. Mellinghoff, Nikolaus Schultz, Paul S. Mischel, Timothy F. Cloughesy

Institutions: Memorial Sloan Kettering Cancer Center, University of California, Los Angeles

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G270565303, The role of mTORC2 in reprogramming cancer cell metabolism, G435997112, G5008160765, Molecular Mechanisms of IDH1-mediated Gliomagenesis, Evolutionary Dynamics of Brain, Lung, and Hematopoietic Tumors, Cancer Center Support Grant

OpenAlex ID: W1902487713

FWCI: 6.914

Cites: 217

Cited by: 34

Related to: 10